Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 677

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 677
---
 of Kineta stockholders’ equity prior to the Effective Time.

Using the closing stock price of Kineta as of April 21, 2025 of $0.28 to estimate the amount of Kineta common shares which would need to
be issued in order to reduce the net working capital deficit to an amount allowed in the amended agreement, 4,663,300 shares would be expected to be issued to the vendors and employees to which the estimated transaction costs pertain in lieu of
cash. Accordingly, the shares

451

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

expected to be issued are reflected through the $4,663 adjustment to Kineta common stock recorded at par value, with the remaining $1,301,061 of the amount being recognized as an adjustment
within Kineta’s Additional paid-in capital. All of the outstanding equity of Kineta at the Effective Time, including these shares issued pursuant to satisfy the net working capital deficit amount
permissible in the amended Merger Agreement will be canceled and will cease to exist at the Effective Time in accordance with the agreement, only representing the right to receive the share of Merger Consideration (as stated in the Introduction).
Refer to adjustment Eas reflected in the pro forma condensed combined balance sheet as of December 31, 2024 to illustrate the cancellation of the Kineta equity as of the Effective time in the unaudited pro forma condensed combined
financial information.

Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations

The pro forma adjustments included in the unaudited pro forma condensed combined statement of operations for the year ended December 31,
2024 are as follows:

AARelating to the Kintara Merger, reflects the Legacy TuHURA reversal of interest expense incurred on the
Notes for the year ended December 31, 2024 of $4,138,301.

BBRelating to the Kintara Merger, reflects the Legacy TuHURA
reversal of the change in fair value of derivative liability associated with make-whole premium that is related to the signed subscription agreements for the year ended December 31, 2024 of $313,772.

CCReflects costs related to the Kintara Merger in the amount of $3,386,840 which pertain to transaction-related expenses incurred by
Kintara subsequent to the date at which historical Kintara financial information is presented in the pro forma condensed combined statement